По вашему запросу найдено документов: 10289
Страница 1 из 1029
Fluvoxamine in the treatment of anxiety-depressive spectrum disorders on the search queries «fluvoxamine», «anxiety-depressive disorders», «anxiety», «depression», «comorbidity
Agomelatine: pharmacological profile, possible application, advantages; [Агомелатин: фармакологический профиль, возможности применения, преимущества] and remission in major depressive disorder of varying severity and generalized anxiety disorder. Agomelatine
The new psychiatric dignosis: disruptive mood dysregulation disorder disorder, conduct disorder and attention deficit with hyperactivity, as well as anxiety. The course
Treatment of anxiety-depressive disorders in medical division patients) in treatment of mild anxiety-depressive disorders in medical division patients with cardiovascular disorders
Психоэмоциональный стресс в генезе психосоматических расстройств of situational anxiety and depression. Patients are characterized by high levels of neuroticism, melancholic
Anxiety and depression in COVID-19: Treatment options [Расстройства тревожно-депрессивного спектра на фоне COVID-19: возможности терапии] frequency of depression (up to 53.5%), anxiety (up to 50.9%), and mixed anxiety/depressive disorders were
Global prevalence and burden of depressive and anxiety disorders in 204 countries and territories in 2020 due to the COVID-19 pandemic, with depressive and anxiety disorders being leading contributors to this burden. The emergence of the COVID-19
DEPRESSION AND DEPRESSION-RELATED DISORDERS AFTER A SUBARACHNOID HEMORRHAGE are depression and depression-related disorders (anxiety, apathy, pathological fatigue, posttraumatic stress
DEPRESSION AND DEPRESSION-RELATED DISORDERS AFTER A SUBARACHNOID HEMORRHAGE are depression and depression-related disorders (anxiety, apathy, pathological fatigue, posttraumatic stress
Страница 1 из 1029
Фасеты
Партнеры
Индексация
